MYLAN LABS LTD FDA Approval ANDA 204363

ANDA 204363

MYLAN LABS LTD

FDA Drug Application

Application #204363

Documents

Letter2017-07-21

Application Sponsors

ANDA 204363MYLAN LABS LTD

Marketing Status

Prescription001

Application Products

001INJECTABLE;INJECTION500MG/VIAL0AMIFOSTINEAMIFOSTINE

FDA Submissions

UNKNOWN; ORIG1AP2017-07-17

Submissions Property Types

ORIG1Null15

TE Codes

001PrescriptionAP

CDER Filings

MYLAN LABS LTD
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 204363
            [companyName] => MYLAN LABS LTD
            [docInserts] => ["",""]
            [products] => [{"drugName":"AMIFOSTINE","activeIngredients":"AMIFOSTINE","strength":"500MG\/VIAL","dosageForm":"INJECTABLE;INJECTION","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"07\/17\/2017","submission":"ORIG-1","actionType":"Approval","submissionClassification":"","reviewPriority":"","inserts":"[{\"name\":\"Letter (PDF)\",\"url\":\"https:\\\/\\\/www.accessdata.fda.gov\\\/drugsatfda_docs\\\/appletter\\\/2017\\\/204363Orig1s000ltr.pdf\"}]","notes":"> Label is not available on this site."}]
            [supplements] => 
            [actionDate] => 2017-07-17
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.